Search Articles — Sudonull

Search Results

In this project

Free AI for code refactoring: Qwen + agents

https://sudonull.com/free-ai-for-code-refactoring-qwen-agents

Set up Qwen with Claude Code and Kilo Code for free: 1000 requests/day. Java Refactoring in 2 min. Guide for middle/senior dev — try without subscription.

Free IT Profession Courses Without Payment

https://sudonull.com/free-it-profession-courses-without-payment

8 completely free self-paced courses on Python, JS, cybersecurity, design. Profession test for beginners. Start learning without investments — basics + practice.

Free NVIDIA API: 100+ models for developers

https://sudonull.com/free-nvidia-api-100-models-for-developers

NVIDIA provides free API access to 100+ neural network models. Learn how to connect, tariff limitations, and usage scenarios. Practical guide for developers.

Free Frontend Courses 2026: Analysis for Tech Leads

https://sudonull.com/free-frontend-courses-2026-analysis-for-tech-leads

How do free Frontend courses in 2026 affect the job market? Recommendations for tech leads on hiring and mentoring juniors. Learn the key trends.

Free 1C Configurations: F³ project for stable systems

https://sudonull.com/free-1c-configurations-f3-project-for-stable-systems

Analysis of the F³ project — a free 1C configuration with open source code. Learn how the modular architecture reduces update costs and increases system stability.

From other projects

mRNA vaccine against glioblastoma: 42% survival in phase 2

https://ymaho.com/mrna-vaccine-against-glioblastoma-42-survival-in-phase-2

Personalized mRNA vaccine showed 42% 18-month recurrence-free survival in glioblastoma. Learn details of the breakthrough JAMA study and prospects of the method.

KRAS G12C colorectal cancer: sotorasib + panitumumab breakthrough

https://ymaho.com/kras-g12c-colorectal-cancer-sotorasib-panitumumab-breakthrough

CodeBreak300 phase 3: Lumakras and Vectibix combination increased progression-free survival by 3 months. Treatment of KRAS G12C metastases approved. How dual blockade breaks 40-year resistance.

Intellia CRISPR therapy: phase 3 data on edema — breakthrough

https://ymaho.com/intellia-crispr-therapy-phase-3-data-on-edema-breakthrough

Intellia presented long-awaited phase III data of CRISPR therapy lonvo-z for hereditary angioedema: 87% reduction in attacks, 62% of patients attack-free. Learn about the breakthrough in in vivo genome editing.

Free Weights vs Machines: Key Difference Explained

https://lrivo.com/free-weights-vs-machines-key-difference-explained

Learn what is the difference between free weights and machines for your goals. Compare safety, muscle growth, cost, and find the best choice for you. Read more.

FDA approved a calibration-free finger blood pressure monitor

https://ymaho.com/fda-approved-a-calibration-free-finger-blood-pressure-monitor

FDA approved Biozen BP1000 — the first calibration-free fingertip blood pressure monitor. Learn how this will change the hypertension market and your health. Read the analysis.

Trending Now